Memory Enhancement Center of America

Recent papers from Memory Enhancement Center of America

1. Biomaterials in Tissue Regeneration Following Surgically Induced Bile Duct Injuries: A Systematic ReviewSurgical Laparoscopy Endoscopy & Percutaneous Techniques · 2026
2. Covalently Coupled Phenylenediamine and Citric Acid-Based Carbon Dots: A Dual-Emissive Architecture for Rapid Optical Cr(VI) Sensing and Live-Cell ImagingACS Omega · 2026
3. Damping identification and settling through energyNoise & Vibration Worldwide · 2026
4. Participants’ characteristics influencing pupillometry parameters in a community in JapanFUKUSHIMA JOURNAL OF MEDICAL SCIENCE · 2025
5. The Role Of Biomarkers In Predicting Neoadjuvant Treatment Response In Gastric CancerEastern Journal Of Medicine · 2025
6. Early Guided Palliative Care Communication for Patients With COVID-19 Receiving ECMOAmerican Journal of Critical Care · 2023
7. How Policies Portray Students: A Discourse Analysis of Codes of Conduct in Academic LibrariesCollege & Research Libraries · 2022
8. THE USE OF Cyperus kyllinga EXTRACT IN SYNTHESIS OF SILVER NANOPARTICLE TO ENHANCE QUALITY OF GOAT LEATHERPERIÓDICO TCHÊ QUÍMICA · 2020
9. Methods for Hardening and Improvement of Fatigue Characteristics of Titanium and Iron-Chromium Nickel Alloy SamplesPERIÓDICO TCHÊ QUÍMICA · 2020
10. Development of a passive Rehabilitation Robot for the wrist joint through the implementation of an Arduino UNO microcontroller2017
11. Contribution of Aboriginal Community-Controlled Health Services to improving Aboriginal health: an evidence reviewAustralian Health Review · 2017
12. Performance of [¹⁸F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's diseaseAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017
13. Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque DensityJAMA Neurology · 2015
14. O3–06–05: Sustained cognitive benefit in patients with mild cognitive impairment (MCI) upon prolonged treatment with CHF5074Alzheimer s & Dementia · 2013
15. Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer DiseaseClinical Neuropharmacology · 2013
16. Successful Treatment of Primary Sclerosing Cholangitis with a Steroid and a ProbioticCase Reports in Gastroenterology · 2012
17. P1‐309: Correlation between baseline measures of amyloid‐positron emission tomography (PET) imaging, cerebral spinal fluid (CSF) biomarkers, and clinical scales in predementia Alzheimer's diseaseAlzheimer s & Dementia · 2011
18. Are γ-secretase inhibitors detrimental for Alzheimer's disease patients?Journal of Alzheimer s Disease · 2010
19. P2‐377: A phase 2, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL‐108 after 12 weeks of intranasal administration in subjects with mild cognitive impairmentAlzheimer s & Dementia · 2008
20. Practice Features Associated With Patient-Reported Accessibility, Continuity, and Coordination of Primary Health CareThe Annals of Family Medicine · 2008